281 related articles for article (PubMed ID: 31091047)
41. What can allostasis tell us about anabolic-androgenic steroid addiction?
Hildebrandt T; Yehuda R; Alfano L
Dev Psychopathol; 2011 Aug; 23(3):907-19. PubMed ID: 21756441
[TBL] [Abstract][Full Text] [Related]
42. Association between narcotic use and anabolic-androgenic steroid use among American adolescents.
Denham BE
Subst Use Misuse; 2009; 44(14):2043-61. PubMed ID: 20001694
[TBL] [Abstract][Full Text] [Related]
43. Knowledge of and Attitudes Toward the Use of Anabolic-Androgenic Steroids among the Population of Jeddah, Saudi Arabia.
Ahmed MH; Al-Saud NS; Omar AM; Magadmi RM; Hassan SM; Al-Qudsi FM
J Microsc Ultrastruct; 2019; 7(2):78-83. PubMed ID: 31293889
[TBL] [Abstract][Full Text] [Related]
44. Hidden Danger of Irrational Abusing Illegal Androgenic-anabolic Steroids in Recreational Athletes Age Under 35 in Bosnia & Herzegovina.
Solakovic S; Totic D; Vukas H; Djedovic M
Med Arch; 2015 Jun; 69(3):200-2. PubMed ID: 26261392
[TBL] [Abstract][Full Text] [Related]
45. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Choi SM; Lee BM
Expert Opin Drug Saf; 2015; 14(11):1773-85. PubMed ID: 26401842
[TBL] [Abstract][Full Text] [Related]
46. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
[TBL] [Abstract][Full Text] [Related]
47. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
[TBL] [Abstract][Full Text] [Related]
48. Heavy Testosterone Use Among Bodybuilders: An Uncommon Cohort of Illicit Substance Users.
Westerman ME; Charchenko CM; Ziegelmann MJ; Bailey GC; Nippoldt TB; Trost L
Mayo Clin Proc; 2016 Feb; 91(2):175-82. PubMed ID: 26769184
[TBL] [Abstract][Full Text] [Related]
49. Knowledge and Awareness About Anabolic-Androgenic Steroid Use as a Body Shape Enhancer and Its Side Effects Among Adult Gym Participants in Jeddah, Saudi Arabia.
Abumunaser I; Salawati E; Albogami S; Alzahrani T; Kabouha Q; Alzahrani J; Almalki A; Alzahrani N
Cureus; 2024 Jan; 16(1):e51747. PubMed ID: 38318561
[TBL] [Abstract][Full Text] [Related]
50. Anabolic androgenic steroids and aggression: studies using animal models.
McGinnis MY
Ann N Y Acad Sci; 2004 Dec; 1036():399-415. PubMed ID: 15817752
[TBL] [Abstract][Full Text] [Related]
51. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.
Albano GD; Amico F; Cocimano G; Liberto A; Maglietta F; Esposito M; Rosi GL; Di Nunno N; Salerno M; Montana A
Healthcare (Basel); 2021 Jan; 9(1):. PubMed ID: 33477800
[TBL] [Abstract][Full Text] [Related]
52. Doping and effects of anabolic androgenic steroids on the heart: histological, ultrastructural, and echocardiographic assessment in strength athletes.
Hassan NA; Salem MF; Sayed MA
Hum Exp Toxicol; 2009 May; 28(5):273-83. PubMed ID: 19755459
[TBL] [Abstract][Full Text] [Related]
53. Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.
Piatkowski T; Robertson J; Lamon S; Dunn M
Harm Reduct J; 2023 Apr; 20(1):56. PubMed ID: 37098574
[TBL] [Abstract][Full Text] [Related]
54. Anabolic-androgenic steroids: medical assessment of present, past and potential users.
O'Sullivan AJ; Kennedy MC; Casey JH; Day RO; Corrigan B; Wodak AD
Med J Aust; 2000 Sep; 173(6):323-7. PubMed ID: 11061405
[TBL] [Abstract][Full Text] [Related]
55. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.
Smit DL; de Hon O; Venhuis BJ; den Heijer M; de Ronde W
Scand J Med Sci Sports; 2020 Mar; 30(3):531-539. PubMed ID: 31663164
[TBL] [Abstract][Full Text] [Related]
56. Impact of anabolic androgenic steroids on COVID-19.
Shaik KM; Patibandla V; Nandi S
Steroids; 2024 Mar; 203():109361. PubMed ID: 38176451
[TBL] [Abstract][Full Text] [Related]
57. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
58. Anabolic-androgenic steroids and athlete's heart: When big is not beautiful....!
D'Andrea A; Limongelli G; Morello A; Mattera Iacono A; Russo MG; Bossone E; Calabrò R; Pacileo G
Int J Cardiol; 2016 Jan; 203():486-8. PubMed ID: 26547743
[No Abstract] [Full Text] [Related]
59. Side-effects of topical androgenic and anabolic substances and steroids. A short review.
Wollina U; Pabst F; Schönlebe J; Abdel-Naser MB; Konrad H; Gruner M; Haroske G; Klemm E; Schreiber G
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Sep; 16(3):117-22. PubMed ID: 17994172
[TBL] [Abstract][Full Text] [Related]
60. Anabolic-Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia.
Albaker W; Alkhars A; Elamin Y; Jatoi N; Boumarah D; Al-Hariri M
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356984
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
